search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
disinfectants. It should be emphasized that rectal lavage using various anthelmintic products is very unlikely to have any effect, as O. equi does not inhabit the rectum or descending colon.


9.9. Bots Bots, though aesthetically displeasing, are very mild pathogens and should not dictate treatment decisions. However, the recommended baseline treatments include a macrocyclic lactone administered in the fall, which would help reduce bot occurrence. Recent data suggest variable efficacy of moxidectin against bot larvae (Reinemeyer et al., 2015), and ivermectin may be a more effective choice.


10. Six Changes Worth Making


• Check anthelmintic efficacy routinely by fecal egg count reduction testing.


• Do not deworm with fixed intervals year-round. • Abandon rotational deworming. • Reduce anthelmintic treatment frequency. • Tailor strongyle parasite control to the active transmission season. • Do not use fecal egg counts to diagnose clinical disease.


Developed by the AAEP Parasite Control Subcommittee of the AAEP Infectious Disease Committee in 2013. Original subcommittee members included: Martin K. Nielsen, DVM, Ph.D., Dipl. EVPC (chair); Linda Mittel, MSPH, DVM; Amy Grice, VMD; Michael Erskine, DVM, Dipl. ABVP; Emily Graves, VMD, Dipl. ACVIM; Wendy Vaala, VMD, Dipl. ACVIM; Richard C. Tully, DVM; Dennis D. French, DVM, Ph.D., Dip. ABVP; Richard Bowman, DVM; and Ray M. Kaplan, DVM, Ph.D., Dipl. ACVM, Dipl. EVPC.


Reviewed and updated in 2024 by the AAEP Internal Parasite Control Guidelines Task Force under the oversight of the AAEP Infectious Disease Committee.


2024 Task Force members: Martin K. Nielsen, DVM, Ph.D., Dipl. EVPC (chair); Michael Erskine, DVM, Dipl. ABVP; Sally Anne L. DeNotta, DVM, Ph.D., Dipl. ACVIM; Dennis D. French, DVM, Ph.D., Dip. ABVP; Emily Graves, VMD, Dipl. ACVIM; Ray M. Kaplan, DVM, Ph.D., Dipl. ACVM, Dipl. EVPC; Sarah Reuss, VMD, Dipl. ACVIM; Eric L. Swinebroad, DVM, Dipl. ACVIM; Wendy Vaala, VMD, Dipl. ACVIM; and Rose D. Nolen-Walston, DVM, Dipl. ACVIM (LAIM).


26


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34